NCT07179783 2025-09-18Sacituzumab Tirumotecan in Combination With Tagitanlimab in the Treatment of Aggressive Variant Prostate Cancer (AVPC) and Neuroendocrine Prostate Cancer (NEPC)Tianjin Medical University Second HospitalPhase 2 Recruiting28 enrolled